OLD Category: immuno-oncology
September 9, 2020 / Cancers
Transcriptional Spatial Profiling of Cancer Tissues in the Era of Immunotherapy: The Potential and Promise
September 8, 2020 / eLife
A perspective on HPK1 as a novel immuno-oncology drug target
September 2, 2020 / Front Oncol
Immune-Related Gene Expression and Cytokine Secretion Is Reduced Among African American Colon Cancer Patients
September 1, 2020 / Cancers (Basel)
Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies
September 1, 2020 / JCO Precision Oncology
Two cases of advanced stage lung adenocarcinoma with radiological complete response to nivolumab treatment harboring a STK11/LKB1 mutation
August 30, 2020 / Oncoimmunology
Primary and metastatic breast tumors cross-talk to influence immunotherapy responses
August 26, 2020 / Cancers (Basel)
Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy
August 26, 2020 / J Immunother Cancer
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
August 26, 2020 / Biomark Res